Zoetis Inc (ZTS)
174.02
+0.32
(+0.18%)
USD |
NYSE |
May 17, 16:00
174.02
0.00 (0.00%)
Pre-Market: 20:00
Zoetis Accounts Receivable (Quarterly): 1.293B for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.293B |
December 31, 2023 | 1.304B |
September 30, 2023 | 1.257B |
June 30, 2023 | 1.322B |
March 31, 2023 | 1.186B |
December 31, 2022 | 1.215B |
September 30, 2022 | 1.189B |
June 30, 2022 | 1.291B |
March 31, 2022 | 1.222B |
December 31, 2021 | 1.133B |
September 30, 2021 | 1.152B |
June 30, 2021 | 1.17B |
March 31, 2021 | 1.125B |
December 31, 2020 | 1.013B |
September 30, 2020 | 1.012B |
June 30, 2020 | 984.00M |
March 31, 2020 | 965.00M |
December 31, 2019 | 1.086B |
September 30, 2019 | 1.03B |
June 30, 2019 | 994.00M |
March 31, 2019 | 970.00M |
December 31, 2018 | 1.036B |
September 30, 2018 | 929.00M |
June 30, 2018 | 973.00M |
March 31, 2018 | 943.00M |
Date | Value |
---|---|
December 31, 2017 | 998.00M |
September 30, 2017 | 1.009B |
June 30, 2017 | 975.00M |
March 31, 2017 | 954.00M |
December 31, 2016 | 913.00M |
September 30, 2016 | 915.00M |
June 30, 2016 | 888.00M |
March 31, 2016 | 908.00M |
December 31, 2015 | 937.00M |
September 30, 2015 | 1.038B |
June 30, 2015 | 993.00M |
March 31, 2015 | 905.00M |
December 31, 2014 | 980.00M |
September 30, 2014 | 1.057B |
June 30, 2014 | 1.098B |
March 31, 2014 | 1.10B |
December 31, 2013 | 1.138B |
September 30, 2013 | 1.11B |
June 30, 2013 | 1.137B |
March 31, 2013 | 861.00M |
December 31, 2012 | 900.00M |
September 30, 2012 | 848.00M |
June 30, 2012 | 889.00M |
March 31, 2012 | 848.00M |
December 31, 2011 | 871.00M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
965.00M
Minimum
Mar 2020
1.322B
Maximum
Jun 2023
1.147B
Average
1.161B
Median
Accounts Receivable (Quarterly) Benchmarks
IDEXX Laboratories Inc | 507.21M |
Pfizer Inc | 10.99B |
ResMed Inc | 779.26M |
Amgen Inc | 6.776B |
Biogen Inc | 2.000B |